Abbott Laboratories buy Raymond James
Start price
25.01.24
/
50%
€102.62
Target price
25.01.25
€116.71
Performance (%)
-6.13%
Price
24.05.24
€95.81
Summary
This prediction is currently active. With a performance of -6.13%, the BUY prediction by Raymond_James is trending in the wrong direction. Dividends of €0.52 are taken into consideration when calculating the performance. This prediction currently runs until 25.01.25. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 0.063% | 0.063% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by Raymond_James for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Raymond James from $124.00 to $127.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Raymond_James for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.30
03.01.24
03.01.24
€113.61
03.01.25
03.01.25
-3.46%
24.05.24
24.05.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€88.90
19.10.23
19.10.23
€104.02
19.10.24
19.10.24
8.92%
24.05.24
24.05.24